SURGICAL
hamburger
product photo

KEEP YOUR PROCEDURES STABLE AND STEADY

The StabilEyes Capsular Tension Ring (CTR) helps deliver stability where it’s needed. Designed for use in cataract surgery for patients with compromised zonules, the CTR helps maintain the integrity of the capsular bag during phacoemulsification and intraocular lens (IOL) implantation.1

CAPSULE STABILITY

When used properly during cataract surgery, the StabilEyes Capsular Tension Ring may help provide capsule stability during phacoemulsification.1

SIMPLE INSERTION

With an easy-to-use design, the StabilEyes Capsular Tension Ring gives surgeons the flexibility to deliver expert care during cataract procedures.

  • Offers micro inserter or forceps-controlled delivery1
  • Can be inserted any time following capsulorhexis and prior to IOL insertion1
StabilEyes Capsular Tension Ring1

Sizes

12.0 mm
13.0 mm

Inserter

Syringe-style micro inserter

REFERENCES

  1. StabilEyes Capsular Tension Ring [package insert]. Santa Ana, Calif: Abbott Medical Optics Inc.

INDICATIONS AND IMPORTANT SAFETY INFORMATION FOR THE STABILEYES CAPSULAR TENSION RING

Rx Only

INDICATIONS

CTRs are indicated for the stabilization of weakened, broken, or missing zonules that are suspected or observed during cataract extraction using phacoemulsification and continuous curvilinear capsulorhexis techniques in adults.

CONTRAINDICATIONS

CTRs should not be used in the presence of a torn or compromised capsular bag or significant, progressive pseudoexfoliation. CTRs should not be used in patients 12 years old or younger due to the developing eye.

WARNINGS

The long-term effects of progressive zonular stability following implantation of a CTR are not known. Patients with pseudoexfoliation syndrome or an otherwise compromised zonule due to trauma exhibit a wide variety and degree of intraoperative and postoperative complications hat must be taken into consideration by the surgeon prior to using the CTR. All subjects with a compromised zonule may not be suitable to receive a CTR. The medical literature has reported that eyes with pseudoexfoliation syndrome and a shallow (below average) anterior chamber depth may exhibit a greater tendency to develop zonular instability, intraoperative and postoperative complications. The use of a CTR in patients less than 18 years of age may increase the risk of radial tears of the capsulorhexis as reported in the medical literature. The safety of the CTR in cases of zonulolysis greater than 33% has not been established.

PRECAUTIONS

The CTR is for single use only. This device may not be reused. This device may not be resterilized. Product is sterile and must remain in its original package until ready for use. Use sterile technique and remain in a sterile field when handling the product. Do not use after expiration date. Do not use if the package is opened or damaged. Inspect product prior to use. Do not use damaged products. Surgeons should be familiar with the CTR insertion technique prior to use. Store between 50 and 85 degrees F

ADVERSE EVENTS

Potential adverse events during or following cataract surgery with the use of a capsular tension ring may include but are not limited to: intraoperative vitreous loss requiring a vitrectomy, zonular instability, zonular dehiscence requiring suturing of IOL, corneal transplant rejection/graft, or retinal detachment. The most frequently reported cumulative adverse event that occurred during the StabilEyes Capsular Tension Ring clinical trial was intraoperative vitreous loss requiring a vitrectomy which occurred at a rate of 2.2%. Other reported events included zonular dehiscence, corneal transplant rejection and retinal detachment all which occurred at a rate of 0.7%.

PP2017MLT0200

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. All other trademarks are the intellectual property of their respective owners.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

true
accessibility
© 2017 Abbott Laboratories Inc. Abbott Park, Illinois, USA. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. All other trademarks are the intellectual property of their respective owners.

YESNO
accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. All other trademarks are the intellectual property of their respective owners.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

YESNO